1. Home
  2. News
  3. JiangXi Tianxin Pharmaceutical Co., Ltd.
  4. Announcement on Convening the Q3 2024 Performance Briefing
More JiangXi Tianxin Pharmaceutical Co., Ltd. news
JiangXi Tianxin Pharmaceutical Co., Ltd.SSE: 603235

Announcement on Convening the Q3 2024 Performance Briefing

Nov 23, 2024 · Issued by JiangXi Tianxin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 23, 2024 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-194

JiangXi Tianxin Pharmaceutical Co., Ltd. on 6ix

Earlier from JiangXi Tianxin Pharmaceutical

  • Announcement on Detention Given to Actual Controller and ChairmanNov 2, 2024
  • Announcement on Operating Data for Q3 2024Oct 30, 2024
  • Announcement on Progress in Repurchasing Company Shares through Call AuctionOct 9, 2024
  • Announcement on Convening the 2024 Semi-annual Performance BriefingSep 24, 2024
  • Announcement on Operating Data in Q2 2024Aug 31, 2024

Later from JiangXi Tianxin Pharmaceutical

  • Announcement on Implementation Result of Repurchasing Shares and Share ChangesJan 22, 2025
  • Announcement on Resolutions of the 7th Meeting of the 3rd Board of DirectorsJan 24, 2025
  • Announcement on Providing Guarantee for Wholly-owned SubsidiaryFeb 6, 2025
  • Announcement on "Corporate Value and Return Enhancement" Action PlanFeb 21, 2025
  • Announcement on Release of Actual Controller and Chairman from DetentionMar 28, 2025
All JiangXi Tianxin Pharmaceutical news releases↗

Follow JiangXi Tianxin Pharmaceutical into a list and get an email when it puts out news.

Follow JiangXi Tianxin Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer